Evidence map›Paper›PMID 40627623›Full record

ArticlePloS one2025

Treponema pallidum infection in asymptomatic persons: A puzzling scenario in the Canary Islands (Spain) (2001-2020).

Jose Luis Pérez-Arellano, Araceli Hernández Betancor, Oscar Sanz Peláez, Jose Curbelo, Michele Hernández Cabrera, Elena Pisos Álamo, Nieves Jaén Sánchez, Laura Suárez Hormiga, Carmen Lavilla Salgado, Laura López Delgado and 2 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jose Luis Pérez-ArellanoUniversity Institute of Biomedical and Health Research (Instituto Universitario de Investigaciones Biomédicas y Sanitarias IUIBS), University of Las Palmas de Gran Canaria (ULPGC), Spain.
Araceli Hernández BetancorMicrobiology and Parasitology Service, Insular University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, Spain.
Oscar Sanz PeláezDepartment of Medical and Surgical Sciences, University of Las Palmas de Gran Canaria (ULPGC), Spain.
Jose CurbeloDepartment of Medicine, University Francisco de Vitoria, Madrid, Spain.
Michele Hernández CabreraDepartment of Medical and Surgical Sciences, University of Las Palmas de Gran Canaria (ULPGC), Spain.
Elena Pisos ÁlamoDepartment of Medical and Surgical Sciences, University of Las Palmas de Gran Canaria (ULPGC), Spain.
Nieves Jaén SánchezDepartment of Medical and Surgical Sciences, University of Las Palmas de Gran Canaria (ULPGC), Spain.
Laura Suárez HormigaDepartment of Medical and Surgical Sciences, University of Las Palmas de Gran Canaria (ULPGC), Spain.
Carmen Lavilla SalgadoDepartment of Medical and Surgical Sciences, University of Las Palmas de Gran Canaria (ULPGC), Spain.
Laura López DelgadoDepartment of Medical and Surgical Sciences, University of Las Palmas de Gran Canaria (ULPGC), Spain.
Sandra González LinaresCanary Institute of Hemodonation and Hemotherapy.
Cristina Carranza-RodríguezUniversity Institute of Biomedical and Health Research (Instituto Universitario de Investigaciones Biomédicas y Sanitarias IUIBS), University of Las Palmas de Gran Canaria (ULPGC), Spain.ORCID https://orcid.org/0000-0002-2768-0072

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesSyphilis is an infectious disease caused by T. pallidum subsp. Pallidum. In high-income countries the main mode of transmission is sexual. Approximately half of infected patients are asymptomatic, which does not exclude the possibility of transmission. The aim of this study was to evaluate syphilis seroprevalence among asymptomatic persons in Gran Canaria (Canary Islands, Spain). PATIENTS AND

methodsThree different groups were studied from 2001 to 2020: i) a "blood donor" sample of 948,869 voluntary blood donations as a proxy of health population.; ii) undocumented African immigrants, including 1,873 recent arrivals in Gran Canaria; and iii) people living with HIV (PLWH), a group of 1,690 patients followed by our team. The evaluation included both treponemal and reaginic tests.

resultsi) among blood donors, the mean seroprevalence of positive treponemal tests was 0.25% (95% CI: 0.19-0.31). Non-treponemal test positivity (RPR) ranged from 0.05 to 0.06% with titers ≤ 1:4 in all cases; ii) thirty-four of 641 undocumented African migrants (5.30%; 95% CI: 3.82-7.32%) had a confirmed positive treponemal test but only 4 had a positive RPR, with titers ranging from 1:1-1:4; iii) 46.51% (95% CI: 44.14-48.89) of PLWH patients had a confirmed positive treponemal test. For factors related to HIV-syphilis coinfection, multivariate analysis clearly showed the association with male sex and the MSM risk category. However, the results of this series call into question the overall role of immigration in the seroprevalence of syphilis among PLWH in our setting. Active syphilis (RPR > 1:8) was found in 20.10% of PLWH.

conclusionsIn summary, syphilis is a re-emerging infection, and asymptomatic persons constitute a group that facilitates its transmission and spread. In our setting, seroprevalence was lowest in blood donors, higher in recently arrived African migrants, and highest in PLWH, especially MSM. The presence of active syphilis however is mainly restricted to MSM. This information is of relevance for the design of syphilis control strategies.

Indexed as

SyphilisTreponema pallidumAdolescentAdultBlood DonorsEmigrants and ImmigrantsFemaleHIV InfectionsHumansMaleMiddle AgedSeroepidemiologic StudiesSpainYoung Adult

Identifiers

PMID40627623
PMCPMC12237060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.